New Immunotherapy Delivery Option for Leptomeningeal Disease in Cancer Patients
University of Texas MD Anderson Cancer Center
Concurrent intrathecal and intravenous treatment is safe and improves outcomes in a subset of patients with melanoma
cancer therapy
Do Lymph Nodes Enhance the Success of Immunotherapy?
University of California - San Francisco
New data show leaving lymph nodes intact until after immunotherapy could boost treatment efficacy
New Insights into T Cell–Tumor Cells Interactions under Immunotherapy
UCLA Health
Study suggests immune responses could be strengthened even in patients showing no apparent clinical response
Can Immunohistochemistry Assays Be Standardized for Cancer Detection?
Zahraa Chorghay, PhD
New synthetic immunohistochemistry reference standards could enable semiquantitative tumor analysis for emerging immunotherapies
New Way to Measure Brain Oxygen Levels in Patients
SPIE—International Society for Optics and Photonics
Noninvasive method allows clinicians to immediately assess the effects of radiotherapy on patients
Key Molecule Driving the Progression of Chronic Leukemia Identified
Swathi Kodaikal, MSc
Further research can alter the prognosis and improve quality of life in patients with leukemia
Clinical Trial Leads to Atezolizumab Approval for Advanced ASPS
National Institutes of Health
The approval of this drug represents a major victory in the fight against rare diseases
Epigenetics Breaks into the Clinical Practice of Cancer
Josep Carreras Leukaemia Research Institute
Researchers describe the impact of epigenetics on cancer treatment and early detection
Experimental Cancer Therapy Shows Success in More than 70% of Patients
Mount Sinai School of Medicine
Directs patients’ immune system to kill multiple myeloma cells
Researchers Generate Lab-Grown Human Tissue Model for Food Tube Cancer
Johns Hopkins Medicine
Researchers discover a model of and potential therapeutic target for gastroesophageal junction cancer